Australia Cardiovascular Devices Market Outlook to 2016

0

Dallas,

 

TX: ReportsandReports announce it will carry Australia Cardiovascular Devices Market Outlook to 2016,Market Research Report in its Store.

Browse the complete Report on: http://www.reportsandreports.com/market-reports/australia-cardiovascular-devices-market-outlook-to-2016/

Australia Cardiovascular Devices Market Outlook to 2016

Summary

GlobalData’s medical device report offering, “Australia Cardiovascular Devices Market Outlook to 2016” provides key market data on the Australia cardiovascular devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – Interventional Cardiology, Peripheral Vascular Devices, Cardiac Rhythm Management, Electrophysiology, Cardiovascular Surgery, Cardiovascular Prosthetic Devices and Cardiovascular Monitoring and Diagnostic Devices. This medical equipment report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Market size and company share data for seven cardiovascular devices market categories – Interventional Cardiology, Peripheral Vascular Devices, Cardiac Rhythm Management, Electrophysiology, Cardiovascular Surgery, Cardiovascular Prosthetic Devices and Cardiovascular Monitoring and Diagnostic Devices.
- Annualized market revenues (USD million), volume (units) and average price ($) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016. 
- 2009 company shares and distribution shares data for each of the seven market categories.
- Global corporate-level profiles of key companies operating within the Australia cardiovascular devices market.
- Key players covered include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical Inc., Cordis Corporation., Abbott Laboratories, Terumo Corporation and C.R. Bard, Inc.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Australia cardiovascular devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

 

Browse:- http://www.reportsandreports.com/market-reports/australia-cardiovascular-devices-market-outlook-to-2016/

 

Table of Content

1 Table of Contents 2


1.1 List of Tables 10
1.2 List of Figures 14


2 Introduction 17


2.1 What Is This Report About? 17


3 Cardiovascular Devices In Australia 18


3.1 Cardiovascular Devices, Market Segmentation 18
3.2 Cardiovascular Devices, Australia, Overall Revenue ($m), 2002-2016 19
3.3 Cardiovascular Devices Market, Australia, Revenue Mix ($m), 2009 21
3.4 Cardiovascular Devices Market, Australia, Category Contribution (%), 2009 22
3.5 Cardiovascular Devices, Australia, Category Volume (Units), 2002-2016 28
3.6 Cardiovascular Devices, Australia, Company Share (2008-2009) 33


4 Cardiac Rhythm Management In Australia 35


4.1 Cardiac Rhythm Management, Market Segmentation 35
4.2 Cardiac Rhythm Management Market, Australia, Revenue Mix ($m), 2009 36
4.3 Cardiac Rhythm Management Market, Australia, Category Contribution (%), 2009 37
4.4 Cardiac Rhythm Management Overall Revenue (2002-2016) 38
4.4.1 Cardiac Resynchronisation Therapy Revenue (2002-2016) 40
4.4.2 Implantable Cardioverter Defibrillator Revenue (2002-2016) 42
4.4.3 Pacemaker Revenue (2002-2016) 44
4.4.4 External Defibrillator Revenue (2002-2016) 46
4.5 Cardiac Rhythm Management Overall Volume (2002-2016) 48
4.5.1 Cardiac Resynchronisation Therapy Volume (2002-2016) 50
4.5.2 Implantable Cardioverter Defibrillator Volume (2002-2016) 52
4.5.3 Pacemaker Volume (2002-2016) 54
4.5.4 External Defibrillator Volume (2002-2016) 56
4.6 Cardiac Rhythm Management Average Price (2002-2016) 58
4.7 Cardiac Rhythm Management Distribution Share (2008-2009) 60
4.8 Cardiac Rhythm Management, Australia, Company Share (2008-2009) 61


5 Cardiovascular Monitoring and Diagnostic Devices In Australia 63


5.1 Cardiovascular Monitoring and Diagnostic Devices, Market Segmentation 63
5.2 Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Revenue Mix ($m), 2009 64
5.3 Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Category Contribution (%), 2009 65
5.4 Cardiovascular Monitoring and Diagnostic Devices Overall Revenue (2002-2016) 66
5.5 Cardiovascular Monitoring and Diagnostic Devices Overall Volume (2002-2016) 69
5.6 Cardiovascular Monitoring and Diagnostic Devices Average Price (2002-2016) 71
5.7 Cardiovascular Monitoring and Diagnostic Devices Distribution Share (2008-2009) 72
5.8 Cardiovascular Monitoring and Diagnostic Devices, Australia, Company Share (2008-2009) 73


6 Cardiovascular Prosthetic Devices In Australia 75


6.1 Cardiovascular Prosthetic Devices, Market Segmentation 75
6.2 Cardiovascular Prosthetic Devices Market, Australia, Revenue Mix ($m), 2009 76
6.3 Cardiovascular Prosthetic Devices Market, Australia, Category Contribution (%), 2009 77
6.4 Cardiovascular Prosthetic Devices Overall Revenue (2002-2016) 78
6.4.1 Cardiac Assist Devices Revenue (2002-2016) 80
6.4.2 Prosthetic Heart Valve Revenue (2002-2016) 82
6.5 Cardiovascular Prosthetic Devices Overall Volume (2002-2016) 84
6.5.1 Cardiac Assist Devices Volume (2002-2016) 86
6.5.2 Prosthetic Heart Valve Volume (2002-2016) 88
6.6 Cardiovascular Prosthetic Devices Average Price (2002-2016) 90
6.7 Cardiovascular Prosthetic Devices Distribution Share (2008-2009) 91
6.8 Cardiovascular Prosthetic Devices, Australia, Company Share (2008-2009) 92


7 Cardiovascular Surgery In Australia 94


7.1 Cardiovascular Surgery, Market Segmentation 94
7.2 Cardiovascular Surgery Market, Australia, Revenue Mix ($m), 2009 95
7.3 Cardiovascular Surgery Market, Australia, Category Contribution (%), 2009 96
7.4 Cardiovascular Surgery Overall Revenue (2002-2016) 97
7.4.1 Perfusion Disposables Revenue (2002-2016) 99
7.5 Cardiovascular Surgery Overall Volume (2002-2016) 101
7.5.1 Perfusion Disposables Volume (2002-2016) 103
7.6 Cardiovascular Surgery Average Price (2002-2016) 105
7.7 Cardiovascular Surgery Distribution Share (2008-2009) 106
7.8 Cardiovascular Surgery, Australia, Company Share (2008-2009) 107


8 Electrophysiology In Australia 108


8.1 Electrophysiology, Market Segmentation 108
8.2 Electrophysiology Market, Australia, Revenue Mix ($m), 2009 109
8.3 Electrophysiology Market, Australia, Category Contribution (%), 2009 110
8.4 Electrophysiology Overall Revenue (2002-2016) 111
8.5 Electrophysiology Overall Volume (2002-2016) 113
8.6 Electrophysiology Average Price (2002-2016) 115
8.7 Electrophysiology Distribution Share (2008-2009) 116
8.8 Electrophysiology, Australia, Company Share (2008-2009) 117

 

9 Interventional Cardiology In Australia 119


9.1 Interventional Cardiology, Market Segmentation 119
9.2 Interventional Cardiology Market, Australia, Revenue Mix ($m), 2009 120
9.3 Interventional Cardiology Market, Australia, Category Contribution (%), 2009 121
9.4 Interventional Cardiology Overall Revenue (2002-2016) 122
9.4.1 Cardiac Catheter Revenue (2002-2016) 125
9.4.2 Coronary Stent Revenue (2002-2016) 127
9.4.3 PTCA Balloon Revenue (2002-2016) 129
9.5 Interventional Cardiology Overall Volume (2002-2016) 131
9.5.1 Cardiac Catheter Volume (2002-2016) 133
9.5.2 Coronary Stent Volume (2002-2016) 135
9.5.3 PTCA Balloon Volume (2002-2016) 137
9.6 Interventional Cardiology Average Price (2002-2016) 139
9.7 Interventional Cardiology Distribution Share (2008-2009) 141
9.8 Interventional Cardiology, Australia, Company Share (2008-2009) 142


10 Peripheral Vascular Devices In Australia 144


10.1 Peripheral Vascular Devices, Market Segmentation 144
10.2 Peripheral Vascular Devices Market, Australia, Revenue Mix ($m), 2009 145
10.3 Peripheral Vascular Devices Market, Australia, Category Contribution (%), 2009 146
10.4 Peripheral Vascular Devices Overall Revenue (2002-2016) 147
10.5 Peripheral Vascular Devices Overall Volume (2002-2016) 151
10.6 Peripheral Vascular Devices Average Price (2002-2016) 155
10.7 Peripheral Vascular Devices Distribution Share (2008-2009) 157
10.8 Peripheral Vascular Devices, Australia, Company Share (2008-2009) 158


11 Overview of Key Companies in Australia Cardiovascular Devices Market 160


11.1 Boston Scientific Corporation 160
11.1.1 Company Overview 160
11.1.2 Share in the Australia Cardiovascular Devices Market 160
11.2 Medtronic, Inc. 161
11.2.1 Company Overview 161
11.2.2 Share in the Australia Cardiovascular Devices Market 161
11.3 St. Jude Medical, Inc. 162
11.3.1 Company Overview 162
11.3.2 Share in the Australia Cardiovascular Devices Market 162
11.4 Cordis Corporation 163
11.4.1 Company Overview 163
11.4.2 Share in the Australia Cardiovascular Devices Market 163
11.5 Abbott Laboratories 164
11.5.1 Company Overview 164
11.5.2 Share in the Australia Cardiovascular Devices Market 164
11.6 Terumo Corporation 165
11.6.1 Company Overview 165
11.6.2 Share in the Australia Cardiovascular Devices Market 165
11.7 BIOTRONIK SE & Co. KG 166
11.7.1 Company Overview 166
11.8 Biosense Webster, Inc. 166
11.8.1 Company Overview 166
11.9 C. R. Bard, Inc. 166
11.9.1 Company Overview 166
11.10 Thoratec Corporation 167
11.10.1 Company Overview 167
11.11 GE Healthcare 167
11.11.1 Company Overview 167
11.12 Philips Healthcare 168
11.12.1 Company Overview 168
11.13 Datascope Corporation 168
11.13.1 Company Overview 168
11.14 Edwards Lifesciences Corporation 168
11.14.1 Company Overview 168
11.15 Welch Allyn Inc. 169
11.15.1 Company Overview 169
11.16 Nihon Kohden Corporation 169
11.16.1 Company Overview 169
11.17 OSI Systems, Inc. 170
11.17.1 Company Overview 170
11.18 Sorin S.p.A. 170
11.18.1 Company Overview 170
11.19 Schiller AG 171
11.19.1 Company Overview 171
11.20 ABIOMED, Inc. 171
11.20.1 Company Overview 171
11.21 Cardiac Science Corporation 171
11.21.1 Company Overview 171
11.22 MAQUET GmbH & Co. KG 172
11.22.1 Company Overview 172
11.23 ev3 Inc. 172
11.23.1 Company Overview 172
11.24 Compumedics Limited 173
11.24.1 Company Overview 173
11.25 AtCor Medical Holdings Limited 173
11.25.1 Company Overview 173
11.26 Uscom Ltd. 173
11.26.1 Company Overview 173
11.27 HD Medical Group Limited 174
11.27.1 Company Overview 174
11.28 Sunshine Heart Company, Pty. Ltd. 174
11.28.1 Company Overview 174
11.29 Ventracor Limited 174
11.29.1 Company Overview 174
11.30 CathRx Ltd 175
11.30.1 Company Overview 175
11.31 BioQ Devices Pty Ltd 175
11.31.1 Company Overview 175


12 Cardiovascular Devices Market Pipeline Products 176


13 Financial Deals Landscape 187


13.1 Acquisition 187
13.1.1 Thoratec Terminates Its Acquisition Of HeartWare International 187
13.2 Partnerships 189
13.2.1 Cardiac Network Signs Licensing Agreement with Pacific Innovations 189
13.2.2 Coherex Medical Enters Into Distribution Agreement With Abbott Laboratories 190
13.2.3 Masimo Enters Into Licensing Agreement With GS Electro Medical Equipment 191


14 Recent Developments 192


14.1 Strategy And Business Planning 192
14.1.1 Oct 10, 2009: Ambu Opens New Entity, Ambu Australia 192
14.2 Government and Public Interest 192
14.2.1 Apr 26, 2010: HeartWare Initiates Repairs And Partial Recall Of Controllers 192
14.2.2 Sep 30, 2009: Study Says Novel Catheter-Based Technique Reduces Resistant Hypertension 193
14.3 Product News 194
14.3.1 Oct 08, 2009: Zenith TX2 TAA Endovascular Graft With Pro-Form From Cook Treats First Patients In Australia 194
14.3.2 Sep 29, 2009: St. Jude Medical Launches New Cardiac Rhythm Management Devices In Australia 195


15 Appendix 196


15.1 Definitions of Markets Covered in the Report 197
15.1.1 Cardiovascular Devices 197
15.2 Research Methodology 204
15.3 Secondary Research 205
15.4 Primary Research 205
15.5 Models 206
15.6 Forecasts 206
15.7 Expert Panels 206
15.8 GlobalData Consulting 206
15.9 Currency Conversion 207
15.10 Contact Us 207
15.11 Disclaimer 207

 

 

Related Reports:

http://www.reportsandreports.com/market-reports/australia-diabetes-care-devices-market-outlook-to-2016/

http://www.reportsandreports.com/market-reports/france-cardiovascular-devices-market-outlook-to-2016/

http://www.reportsandreports.com/market-reports/italy-cardiovascular-devices-market-outlook-to-2016/

About Us
ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.


Contact:

Ms. Sunita
7557 Rambler road,

Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.reportsandreports.com/
Blog: http://reportsnreports.wordpress.com/

 

Customer comments

No comments were found for Australia Cardiovascular Devices Market Outlook to 2016. Be the first to comment!